eris lifesciences

Improved global sentiments are likely to instill strength in domestic markets on Friday. As of 8:00 am, the SGX Nifty suggested a gap-up start as it quoted around 17,136 levels, up over 100 points.…

Prabhudas Lilladher has buy call on Eris Lifesciences with a target price of Rs 850. The current market price of . is Rs 655.15. Time period given by analyst is one year when Ltd. price can reach defined target. Eris Lifesciences Ltd.,…

Eris, one of India’s leading players in the Oral Diabetes Care segment, will now extend its product offering to insulins and GLP1 agonists.The 70:30 Joint Venture (with Eris holding a 70% stake) will primarily engage in marketing and…

Nifty futures on the Singapore Exchange traded 28.5 points, or 0.17 per cent higher at 17,263.50, signaling that Dalal Street was headed for a positive start on Monday. Here are a dozen stocks which may buzz the most in today's trade: Tata…